Journal article

Copper levels are increased in the cerebral cortex and liver of APP and APLP2 knockout mice

AR White, R Reyes, JFB Mercer, J Camakaris, H Zheng, AI Bush, G Multhaup, K Beyreuther, CL Masters, R Cappai

Brain Research | ELSEVIER SCIENCE BV | Published : 1999

Abstract

The pathological process in Alzheimer's disease (AD) involves amyloid beta (Aβ) deposition and neuronal cell degeneration. The neurotoxic Aβ peptide is derived from the amyloid precursor protein (APP), a member of a larger gene family including the amyloid precursor-like proteins, APLP1 and APLP2. The APP and APLP2 molecules contain metal binding sites for copper and zinc. The zinc binding domain (ZnBD) is believed to have a structural rather than a catalytic role. The activity of the copper binding domain (CuBD) is unknown, however, APP reduces copper (II) to copper (I) and this activity could promote copper-mediated neurotoxicity. The expression of APP and APLP2 in the brain suggests they ..

View full abstract

University of Melbourne Researchers